Literature DB >> 31386054

Clinical implications of motor deficits related to brain tumors.

Christina Amidei1, David S Kushner1.   

Abstract

Motor deficits, including unilateral or bilateral weakness, plegia, ataxia, spasticity, and loss of complex movement execution, can occur during any brain tumor illness. Tumor location, treatment effects, and medications contribute to these deficits. Motor dysfunction has been associated with significant deterioration in health-related quality of life in patients with primary and metastatic brain tumors. Significant decrease in median overall survival has been reported in patients with motor deficits, although the reasons for this are unclear. Motor deficits, particularly gait impairment, contribute to significant symptom burden at end of life, and are the most common reasons for initiation of hospice care. Interventions must focus on prevention and amelioration of motor dysfunction throughout the disease course in order to preserve quality of life. The impact of exercise in prolonging survival and improving quality of life requires further study.

Entities:  

Keywords:  functional status; motor deficits; quality of life

Year:  2015        PMID: 31386054      PMCID: PMC6664611          DOI: 10.1093/nop/npv017

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


  8 in total

1.  Personalised and progressive neuromuscular electrical stimulation (NMES) in patients with cancer-a clinical case series.

Authors:  Dominic O'Connor; Matilde Mora Fernandez; Gabriel Signorelli; Pedro Valero; Brian Caulfield
Journal:  Support Care Cancer       Date:  2019-02-08       Impact factor: 3.603

2.  Assessing mobility in primary brain tumor patients: A descriptive feasibility study using two established mobility tests.

Authors:  James L Rogers; Julianie De La Cruz Minyety; Elizabeth Vera; Alvina A Acquaye; Samuel S Payén; Jeffrey S Weinberg; Terri S Armstrong; Shiao-Pei S Weathers
Journal:  Neurooncol Pract       Date:  2022-02-17

3.  Behavioral outcome among survivors of childhood brain tumor: a case control study.

Authors:  Hamidah Alias; Sasirekha Krisnan Morthy; Syed Zulkifli Syed Zakaria; Zulaiha Muda; Azmi Mohd Tamil
Journal:  BMC Pediatr       Date:  2020-02-05       Impact factor: 2.125

4.  Preoperative Transcranial Direct Current Stimulation in Glioma Patients: A Proof of Concept Pilot Study.

Authors:  Stefan Lang; Liu Shi Gan; Cael McLennan; Adam Kirton; Oury Monchi; John J P Kelly
Journal:  Front Neurol       Date:  2020-11-19       Impact factor: 4.003

5.  Potential Neurotoxic Effects of Glioblastoma-Derived Exosomes in Primary Cultures of Cerebellar Neurons via Oxidant Stress and Glutathione Depletion.

Authors:  Sidika Genc; Manuela Pennisi; Yesim Yeni; Serkan Yildirim; Giuseppe Gattuso; Meric A Altinoz; Ali Taghizadehghalehjoughi; Ismail Bolat; Aristidis Tsatsakis; Ahmet Hacımüftüoğlu; Luca Falzone
Journal:  Antioxidants (Basel)       Date:  2022-06-23

Review 6.  A data-centric artificial intelligent and extended reality technology in smart healthcare systems.

Authors:  Tawseef Ayoub Shaikh; Tabasum Rasool Dar; Shabir Sofi
Journal:  Soc Netw Anal Min       Date:  2022-09-01

Review 7.  Exploring Novel Molecular Targets for the Treatment of High-Grade Astrocytomas Using Peptide Therapeutics: An Overview.

Authors:  Giulia Guidotti; Liliana Brambilla; Daniela Rossi
Journal:  Cells       Date:  2020-02-20       Impact factor: 6.600

Review 8.  Functional Decline in the Cancer Patient: A Review.

Authors:  Jaidyn Muhandiramge; Suzanne G Orchard; Erica T Warner; Gijsberta J van Londen; John R Zalcberg
Journal:  Cancers (Basel)       Date:  2022-03-08       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.